Metabolic Health Strategies with Chiropractic Restoration

Learn the importance of chiropractic restoration for metabolic health to achieve optimal physical performance and health.

Abstract

Chronic disease and unresolving injury share a common root in declining cellular energy. Nicotinamide adenine dinucleotide (NAD+) is the essential coenzyme that powers mitochondrial oxidative phosphorylation, supports DNA repair, regulates inflammation through sirtuin pathways, and maintains redox balance. As NAD+ levels fall with age, metabolic stress, trauma, and chronic inflammation, cells lose the capacity to produce ATP efficiently, clear reactive oxygen species, and repair tissue. This bioenergetic failure contributes to atherosclerotic plaque progression, heart failure and dilated cardiomyopathy, insulin resistance and Type 2 diabetes, neurodegenerative changes often described as Type 3 diabetes or Alzheimer’s disease, and prolonged recovery from musculoskeletal injury.

This educational post, written from the clinical perspective of Dr. Alexander Jimenez, DC, APRN, FNP-BC, CFMP, IFMCP, ATN, CCST, synthesizes current evidence from leading researchers and explains how these findings translate into practical, non-surgical care. It describes the physiology of NAD+ depletion, how targeted restoration supports vascular, cardiac, metabolic, and neural health, and how integrative chiropractic care fits within a broader functional and internal-medicine framework. At Injury Medical Clinic PA (also known as Mission Plaza Injury Medical Clinic) in El Paso, Texas, Dr. Jimenez works collaboratively with Dr. Maria Guadalupe Cardenas, MD, Board Certified in Internal Medicine (NPI #1164426749, Texas MD License #J2933). With more than 40 years of internal medicine experience, Dr. Cardenas serves as Medical Director and Collaborative Physician, providing medical oversight while Dr. Jimenez delivers chiropractic, functional medicine, and rehabilitative care. This post explains how this multidisciplinary model addresses both the cellular and biomechanical drivers of chronic inflammation and delayed healing, offering patients a coordinated path to restored function and tissue longevity.

Understanding NAD+ and Mitochondrial Bioenergetics: The Foundation of Cellular Energy

Every physiological process—from the contraction of a spinal stabilizer muscle to the enzymatic clearance of an inflammatory cytokine—requires continuous access to adenosine triphosphate (ATP). Enzymes accelerate the chemical reactions that generate and use ATP, yet enzymes cannot work alone. They depend on coenzymes that shuttle electrons and stabilize intermediate molecules. Among them, NAD+ serves as the cell’s universal molecular toolkit.

NAD+ cycles between its oxidized form (NAD+) and its reduced form (NADH). This cycling is indispensable for four core energy pathways:

• Cytosolic glycolysis, where NAD+ accepts electrons at the glyceraldehyde-3-phosphate dehydrogenase step.
• Mitochondrial beta-oxidation of fatty acids.
• The tricarboxylic acid (TCA or Krebs) cycle, in which NAD+ accepts electrons at isocitrate dehydrogenase, alpha-ketoglutarate dehydrogenase, and malate dehydrogenase.
• Oxidative phosphorylation, in which NADH donates electrons to Complex I of the electron-transport chain, driving proton pumping and ATP synthesis at Complex V.

When NAD+ concentrations decline, these pathways slow. Cells shift toward less efficient glycolysis, accumulate reactive oxygen species, and eventually enter senescence or apoptosis. In clinical practice at Injury Medical Clinic PA, patients with chronic musculoskeletal pain, metabolic syndrome, or post-traumatic fatigue frequently present with laboratory and functional signs consistent with this bioenergetic deficit. Restoring NAD+ availability therefore becomes a foundational intervention that supports every subsequent mechanical and rehabilitative step.

Redox and Non-Redox Roles of NAD+: How One Molecule Governs Energy and Repair

NAD+ is not merely an electron carrier. In non-redox pathways, three major enzyme families consume it as a substrate.

Sirtuins (SIRT1–SIRT7) remove acetyl groups from histones and metabolic proteins. SIRT1 deacetylates PGC-1? to promote mitochondrial biogenesis and deacetylates the p65 subunit of NF-?B to dampen pro-inflammatory gene expression. SIRT3, located in the mitochondrial matrix, activates superoxide dismutase 2 and electron-transport-chain complexes, limiting oxidative damage while maximizing ATP output. SIRT6 supports DNA repair and telomere maintenance.

Poly(ADP-ribose) polymerases (PARP1 and PARP2) detect DNA strand breaks and polymerize ADP-ribose chains onto repair proteins. Under chronic oxidative or mechanical stress, PARP1 hyperactivation rapidly depletes the NAD+ pool, starving sirtuins and collapsing ATP production.

CD38 and CD157, the primary NAD+ consumers in many tissues, generate cyclic ADP-ribose that modulates calcium signaling. Inflammatory M1 macrophages express high levels of CD38; as these cells accumulate in vessel walls, adipose tissue, or synovial linings, they create local NAD+ deserts that impair neighboring parenchymal cells.

Clinical observations recorded at healthcoach.clinic emphasize that patients recovering from trauma or living with metabolic disease often exhibit elevated inflammatory markers (hs-CRP, ferritin) alongside signs of mitochondrial inefficiency. Supporting NAD+ while reducing mechanical sources of inflammation creates a synergistic environment that supports enzymatic repair and tissue remodeling.

Atherosclerosis and Vascular Endothelial Health: How NAD+ Stabilizes Plaques

Atherosclerosis begins with endothelial injury driven by shear stress, oxidized LDL, hyperglycemia, and circulating cytokines. In a low-NAD+/low-SIRT1 environment, endothelial nitric oxide synthase (eNOS) becomes uncoupled and produces superoxide instead of protective nitric oxide. Adhesion molecules (VCAM-1, ICAM-1, MCP-1) are upregulated, monocytes infiltrate, and macrophages become foam cells. These cells secrete matrix metalloproteinases that thin the fibrous cap and enlarge the necrotic core, setting the stage for plaque rupture.

Restoring NAD+ reverses several of these steps. SIRT1 deacetylates eNOS at key lysine residues, restoring nitric oxide production. This deacetylation also suppresses NF-?B-driven transcription of adhesion molecules, limiting further monocyte entry. Adequate NAD+ favors macrophage repolarization toward an anti-inflammatory M2 phenotype that clears apoptotic debris (efferocytosis) and reduces MMP activity, thereby stabilizing the fibrous cap. Mateuszuk and colleagues (2020) demonstrated that nicotinamide mononucleotide replenishment reduced plaque size, lowered vascular inflammation, and improved endothelial function in dyslipidemic models (Mateuszuk et al., 2020).

In the clinic, Dr. Cardenas provides internal-medicine oversight of cardiovascular risk factors—lipid subfractions, blood-pressure management, and glycemic control—while Dr. Jimenez integrates spinal and soft-tissue care that reduces sympathetic overdrive and improves peripheral perfusion. Patients with personal-injury-related cervical or thoracic trauma frequently show concurrent endothelial stress; addressing both the mechanical and bioenergetic components accelerates functional recovery without reliance on invasive vascular procedures.

Cardiac Bioenergetics, Heart Failure, and Dilated Cardiomyopathy

The adult heart turns over about 6 kg of ATP each day, deriving 60–80% of that energy from fatty-acid oxidation. Intracellular ATP stores are minimal, so the heart must continuously recycle ATP through mitochondria. In heart failure, the myocardium shifts toward less efficient glycolysis, NAD+ declines, and SIRT3 activity falls. Respiratory-chain complexes become hyperacetylated, electron transport uncouples, and reactive oxygen species rise. Calcium handling deteriorates because SERCA2a is oxidized and the ryanodine receptor leaks; the mitochondrial permeability transition pore opens, releasing cytochrome c and triggering cardiomyocyte apoptosis. Fibroblasts then replace lost myocytes with non-contractile collagen, dilating the ventricle and reducing ejection fraction.

Exogenous NAD+ precursor delivery reverses this cascade. Diguet et al. (2018) showed that nicotinamide riboside restored myocardial NAD+ levels, improved fractional shortening and ejection fraction, and reversed eccentric remodeling in models of dilated cardiomyopathy (Diguet et al., 2018). Mechanistically, reactivated SIRT3 deacetylates Complex I, suppresses superoxide, normalizes SERCA2a function, and limits fibrotic signaling.

At Injury Medical Clinic PA, patients presenting after motor-vehicle collisions or occupational injuries sometimes carry undiagnosed or poorly controlled cardiometabolic disease. Dr. Cardenas’ medical evaluation includes cardiac risk stratification and laboratory monitoring, while Dr. Jimenez’s chiropractic and rehabilitative protocols reduce the mechanical load on the thorax and improve autonomic balance. Clinical notes published at healthcoach.clinic highlight that patients who receive concurrent metabolic support and spinal care often report faster resolution of fatigue and improved exercise tolerance once the bioenergetic deficit is addressed.

Type 2 Diabetes Mellitus as a Mitochondrial Bioenergetic Disorder

Although Type 2 diabetes is diagnosed by hyperglycemia, its cellular origin lies in nutrient overload that floods the electron-transport chain. Excess NADH and FADH2 create a high proton gradient that stalls forward electron flow; electrons leak onto oxygen, generating superoxide. Lipid-peroxidation products activate JNK and IKK-?, which phosphorylate IRS-1 on serine residues. This inhibitory phosphorylation blocks downstream PI3K/Akt signaling, traps GLUT4 vesicles intracellularly, and produces insulin resistance. Pancreatic beta cells, already low in antioxidant enzymes, undergo oxidative apoptosis once continuous glucose metabolism consumes NAD+.

Replenishing NAD+ interrupts the cycle. Yoshino et al. (2021) reported that nicotinamide mononucleotide increased muscle insulin sensitivity, enhanced Akt and mTOR phosphorylation, and upregulated genes involved in muscle remodeling in overweight or obese postmenopausal women with prediabetes (Yoshino et al., 2021). SIRT1 deacetylates and activates Akt, promotes PGC-1?-driven antioxidant expression, and reduces NF-?B-mediated cytokine production.

Integrative chiropractic care contributes by restoring joint mechanics and reducing chronic nociceptive input that sustains sympathetic drive and cortisol elevation—both of which worsen insulin resistance. Functional-medicine laboratory panels ordered under Dr. Cardenas’ direction (HOMA-IR, NMR lipoprofile, hs-CRP) allow precise tracking of metabolic progress. At the same time, Dr. Jimenez implements spinal adjustments, spinal decompression, and targeted exercise that improve glucose disposal through increased muscle activity and autonomic recalibration. Observations shared on healthcoach.clinic note that patients who combine these approaches frequently achieve measurable reductions in inflammatory markers and improvements in energy long before large changes in body weight occur.

Neurodegeneration, Type 3 Diabetes, and Alzheimer’s Disease

The brain consumes roughly 20% of resting glucose and oxygen despite representing only 2% of body mass. Early in the Alzheimer’s cascade—often decades before clinical memory loss—endothelial GLUT1 and neuronal GLUT3 transporters down-regulate, creating cerebral hypometabolism and NAD+ depletion. Mitochondrial Complex I uncouples, releasing reactive oxygen and nitrogen species that oxidize synaptic membranes. Oxidative stress and low SIRT1 activity increase BACE1 transcription via NF-?B, shifting amyloid-precursor-protein processing toward neurotoxic A? 1-42. Concurrently, impaired insulin signaling activates GSK-3? and inhibits PP2A, hyperphosphorylating tau and collapsing axonal transport. Activated microglia express CD38, further depleting local NAD+ and amplifying neuroinflammation.

Fang et al. (2019) demonstrated that stimulating mitophagy through NAD+ supplementation reduced insoluble amyloid, suppressed neuroinflammation, and reversed cognitive deficits in multiple Alzheimer’s models (Fang et al., 2019). SIRT1 and SIRT3 activation favors non-amyloidogenic processing, clears damaged mitochondria, and preserves synaptic integrity.

In the El Paso clinic, patients with post-traumatic brain symptoms or chronic neck pain that impairs cerebral blood-flow regulation are evaluated with both functional neurological testing and metabolic panels. Dr. Jimenez’s cranial-cervical and spinal protocols improve mechanoreceptive input and venous drainage, while NAD+ support and targeted nutrition address the bioenergetic substrate. Dr. Cardenas oversees any concurrent internal-medicine issues (hypertension, dyslipidemia, glycemic control) that affect cerebrovascular health. Clinical commentary on LinkedIn and healthcoach.clinic underscores that restoring both mechanical alignment and cellular energy often yields clearer cognitive function and reduced headache burden in this population.

Evidence Milestones That Shift Care from Symptom Management to Root-Cause Restoration

Key translational studies have moved the field from purely symptomatic approaches toward bioenergetic restoration:

• Mateuszuk et al. (2020) showed plaque-size reduction and fibrous-cap stabilization with NAD+ precursor therapy in dyslipidemic models.
• Diguet et al. (2018) documented reversal of dilated cardiomyopathy remodeling and improved ejection fraction.
• Hou et al. (2018) and Fang et al. (2019) linked NAD+ restoration to reduced mitochondrial ROS, enhanced mitophagy, and preserved synaptic connectivity in Alzheimer’s models.
• Yoshino et al. (2021) provided human data demonstrating improved muscle insulin sensitivity after NMN supplementation.

These findings inform the protocols used at Injury Medical Clinic PA. Rather than treating elevated glucose, cholesterol, or pain scores in isolation, the team measures and supports the upstream NAD+-dependent pathways while simultaneously correcting the biomechanical stressors that perpetuate inflammation.

Integrative Chiropractic Care Within Non-Surgical Treatment Pathways

Neuromusculoskeletal injury and metabolic disease are not separate domains. Spinal subluxation or facet hypomobility silences deep mechanoreceptors while over-activating nociceptors. The resulting dorsal-horn sensitization drives segmental muscle spasm, local ischemia, and continuous free-radical generation. Damaged fibroblasts and chondrocytes activate PARP1, which consumes local NAD+ and stalls collagen remodeling. Disorganized Type-III collagen accumulates, producing non-compliant scar tissue and recurrent instability.

High-velocity, low-amplitude chiropractic adjustments restore joint kinematics, deliver an afferent burst that inhibits nociception via gate-control mechanisms, and reset gamma-motor loops. Restored motion provides healthy mechanotransduction signals that encourage tenocytes and chondrocytes to lay down organized Type-I collagen. When these mechanical interventions are paired with NAD+ replenishment, the cells possess the ATP and sirtuin activity required to complete remodeling rather than remain locked in chronic inflammation.

Additional non-surgical tools used under the collaborative model include:

• Computerized spinal decompression that lowers intradiscal pressure and improves nutrient diffusion.
• Instrument-assisted soft-tissue mobilization that disrupts fibrotic restrictions and stimulates local perfusion.
• Proprioceptive neuromuscular facilitation and targeted stabilization exercises that retrain motor patterns.
• Time-restricted feeding and anti-inflammatory dietary patterns that support mitochondrial biogenesis.

Dr. Jimenez’s clinical observations, documented across healthcoach.clinic and professional profiles, emphasize that patients who receive both precise adjustments and metabolic support recover range of motion and report lower pain scores more rapidly than those managed with either modality alone. The dual licensure (DC and APRN/FNP-BC) allows seamless integration of biomechanical correction with laboratory-guided functional-medicine interventions. At the same time, Dr. Cardenas supplies the internal-medicine oversight necessary for patients with complex comorbidities or personal-injury documentation requirements.

Multidisciplinary Protocols at Injury Medical Clinic PA

The clinic’s care architecture places Dr. Maria Guadalupe Cardenas, MD, as Medical Director and Collaborative Physician. Her more than four decades of internal medicine experience guide cardiovascular risk stratification, comprehensive laboratory interpretation, medication management or weaning when appropriate, and clearance for rehabilitative procedures. Dr. Jimenez, with credentials including DC, APRN, FNP-BC, CFMP, IFMCP, ATN, and CCST, conducts biomechanical and functional-neurological examinations, delivers chiropractic adjustments, implements subcutaneous or parenteral NAD+ protocols under collaborative care, and designs active rehabilitation programs.

A typical pathway for a patient with post-collision soft-tissue injury and underlying metabolic disease proceeds through four phases:

1. Comprehensive diagnostics: inflammatory markers (hs-CRP, ESR, homocysteine, ferritin), glycemic indices (fasting insulin, HbA1c, HOMA-IR), advanced lipid subfractions, and micronutrient assessment, combined with digital motion analysis and spinal imaging.
2. Bioenergetic restoration: titrated subcutaneous NAD+ or precursor therapy, sirtuin-activating compounds (resveratrol/pterostilbene), CD38 inhibitors (quercetin, apigenin), and methylation support (methylcobalamin, 5-MTHF, TMG).
3. Mechanical correction: segmental HVLA adjustments, spinal decompression, and soft-tissue mobilization directed at identified fixations and scar tissue.
4. Functional re-education: core stabilization, proprioceptive training, and lifestyle modifications that sustain mitochondrial health.

Continuous dual-discipline monitoring allows real-time adjustment of both medical and mechanical interventions. Patients benefit from a single coordinated plan rather than fragmented care across multiple offices.

Frequently Asked Questions

• What is the primary difference between oral NAD+ precursors and subcutaneous NAD+?
  Oral precursors undergo extensive first-pass metabolism and can be degraded by intestinal CD38. Subcutaneous administration delivers the coenzyme directly into systemic circulation, bypassing the gut and providing higher, more sustained tissue levels to muscle, ligament, and neural tissues.
• How does a chiropractic adjustment support mitochondrial metabolism?
  By restoring joint motion and reducing abnormal shear and hypoxia, the adjustment lowers local free-radical production and PARP1 activation. Preserved NAD+ allows sirtuins to function, supporting ATP generation and orderly tissue repair.
• Why is Alzheimer’s disease sometimes called Type 3 diabetes, and how does NAD+ help?
  The brain develops insulin resistance and impaired glucose transport, starving neurons of fuel and uncoupling mitochondria. NAD+ restoration activates SIRT1 and SIRT3, promotes mitophagy, favors non-amyloidogenic processing, and protects synaptic architecture.
• Can NAD+ restoration reverse established cardiovascular disease?
  Preclinical and emerging human data indicate that NAD+ replenishment improves endothelial nitric oxide production, reduces vascular inflammation, repolarizes macrophages, normalizes myocardial calcium handling, and limits fibrosis—functional changes that can stabilize plaques and improve ejection parameters.
• How does the MD–DC/APRN collaboration benefit personal-injury and chronic-disease patients?
  Dr. Cardenas provides board-certified internal medicine evaluation, diagnostic oversight, and medical clearance. Dr. Jimenez integrates precise chiropractic care, functional-medicine protocols, and rehabilitation. The result is simultaneous resolution of mechanical joint dysfunction and the underlying metabolic deficits that otherwise prolong recovery.

Conclusion and Clinical Summary

Declining NAD+ is a shared upstream driver of atherosclerotic disease, heart failure, Type 2 diabetes, neurodegenerative change, and stalled musculoskeletal repair. Symptom-directed therapies that ignore this bioenergetic foundation and the concurrent biomechanical stressors rarely produce durable resolution. At Injury Medical Clinic PA in El Paso, the collaborative model led by Dr. Alexander Jimenez, DC, APRN, FNP-BC, CFMP, IFMCP, ATN, CCST, and Medical Director Dr. Maria Guadalupe Cardenas, MD, combines evidence-based NAD+ restoration, targeted micronutrient support, precise chiropractic adjustment, active rehabilitation, and comprehensive internal-medicine oversight. By addressing both cellular energy deficits and mechanical sources of ongoing inflammation, the team helps patients restore function, stabilize metabolic markers, and build long-term tissue resilience.

References

• Diguet, N., Trammell, S. A. J., Tannous, C., Deloux, R., Piquereau, J., Mougenot, N., Gouge, A., Gressette, M., Manoury, B., Blanc, J., Breton, M., Sambin, L., O’Brien, M., N’Guyen, T. D., Mercadier, J. J., Brenner, C., & Garnier, A. (2018). Nicotinamide riboside preserves cardiac function in a mouse model of dilated cardiomyopathy. Circulation, 137(21), 2256–2273.
• Fang, E. F., Hou, Y., Palikaras, K., Adriaanse, B. A., Kerr, J. S., Yang, B., Lautrup, S., Hasan-Olive, M. M., Caponio, D., Dan, X., Rocktäschel, P., Croteau, D. L., Akbari, M., Greig, N. H., Fladby, T., Nilsen, H., Cader, M. Z., Mattson, M. P., Tavernarakis, N., & Bohr, V. A. (2019). Mitophagy inhibits amyloid-beta and tau pathology and reverses cognitive deficits in models of Alzheimer’s disease. Nature Neuroscience, 22(3), 401–412.
• Hou, Y., Wei, Y., Lautrup, S., Yang, B., Wang, Y., Cordonnier, S., Mattson, M. P., Croteau, D. L., & Bohr, V. A. (2018). NAD+ supplementation normalizes key Alzheimer’s features and DNA damage responses in a new AD mouse model with introduced DNA repair deficiency. Proceedings of the National Academy of Sciences, 115(8), E1876–E1885.
• Mateuszuk, ?., Campagna, R., Kutryb-Zaj?c, B., Ku?, K., S?ominska, E. M., Smolenski, R. T., & Chlopicki, S. (2020). Reversal of endothelial dysfunction by nicotinamide mononucleotide via extracellular conversion to nicotinamide riboside. Biochemical Pharmacology, 178, 114019.
• Yoshino, M., Yoshino, J., Kayser, B. D., Patti, G. J., Franczyk, M. P., Mills, K. F., Sindelar, M., Pietka, T., Patterson, B. W., Klein, S., & Imai, S. I. (2021). Nicotinamide mononucleotide increases muscle insulin sensitivity in prediabetic women. Science, 372(6547), 1224–1229.
• Additional supporting literature on NAD+ metabolism, sirtuin biology, and integrative neuromusculoskeletal care is referenced throughout the clinical observations published at healthcoach.clinic and in Dr. Jimenez’s professional profiles.

SEO Tags

NAD+ therapy, mitochondrial bioenergetics, subcutaneous NAD+, sirtuins, SIRT1, SIRT3, atherosclerosis plaque regression, dilated cardiomyopathy, Type 2 diabetes pathophysiology, Type 3 diabetes, Alzheimer’s disease, integrative chiropractic care, functional medicine, Dr Alex Jimenez DC, Dr Maria Guadalupe Cardenas MD, Injury Medical Clinic PA, Mission Plaza Injury Medical Clinic, El Paso Texas, spinal biomechanics, oxidative stress, PARP1, CD38, non-surgical treatment, personal injury rehabilitation, insulin resistance, heart failure, endothelial dysfunction, mitophagy, collaborative care, internal medicine and chiropractic integration.